Metachronous Intraductal Papillary Neoplasm of the Bile Duct and Intraductal Papillary Mucinous Neoplasm of the Pancreas in a Patient Diagnosed With Mucinous Adenocarcinoma. [PDF]
, 2019 Intraductal papillary neoplasm of the bile duct (IPNB) is a rare biliary tumor, which shares some radiologic and histologic similarities with pancreatic intraductal papillary mucinous neoplasm (IPMN).
Brennan, Gregory T, Lee, John G
core +1 more source
Formation of Pancreatoduodenal Fistula in Intraductal Papillary Mucinous Neoplasm of the Pancreas Decreased the Frequency of Recurrent Pancreatitis [PDF]
, 2019 Intraductal papillary mucinous neoplasms (IPMN) of the pancreas are characterized by proliferation of mucin-secreting cells in the main pancreatic duct (PD) or its branches. The secreted thick mucin usually leads to PD obstruction and dilation.
Alkaade, Samer +3 more
core +1 more source
Intraductal papillary neoplasm of the bile duct
World Journal of Gastroenterology, 2013 Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. IPNBs are mainly found in patients from Far Eastern areas, where hepatolithiasis and clonorchiasis are endemic.
Xue-Shuai, Wan +7 more
openaire +2 more sources
Collision of ductal adenocarcinoma and neuroendocrine tumor of the pancreas: a case report and review of the literature [PDF]
, 2017 Background: Simultaneous occurrence of exocrine and neuroendocrine tumors of the pancreas is very infrequent. We report a patient with an endocrine tumor in the pancreatic-duodenal area and extensive exocrine carcinoma involving the whole pancreas.
Blandamura, Stella +6 more
core +2 more sources
Neoplastic Progression in Intraductal Papillary Neoplasm of the Bile Duct
Archives of Pathology & Laboratory Medicine, 2023 Context.— Intraductal papillary neoplasm of the bile duct (IPNB) is classified into types 1 and 2 based on criteria proposed in 2019. Recent studies investigated the clinicopathologic and molecular features of IPNB, which contributed to a more detailed understanding of this undercharacterized neoplasm.
Yoh, Zen, Masayuki, Akita
openaire +2 more sources
Endoscopic diagnosis of intraductal papillary mucinous neoplasm of the bile duct [PDF]
Journal of Hepato-Biliary-Pancreatic Sciences, 2009 AbstractBackground/PurposeIntraductal papillary mucinous neoplasm of the bile duct (IPMN‐B) is considered an uncommon tumor. The purpose of this study was to evaluate the diagnostic utility of endoscopic cholangiography (ERC) with subsequent peroral cholangioscopy (POCS) and/or intraductal ultrasonography (IDUS) for this tumor.MethodsFrom December 1991
Toshio, Tsuyuguchi +7 more
openaire +5 more sources
postulating a common tumor entity [PDF]
, 2016 The set definition of distal cholangiocarcinomas and adenocarcinomas of the pancreatic head is challenged by their close anatomical relation, similar growth pattern, and corresponding therapeutic outcome. They show a mutual development during embryologic
Bahra, Marcus +4 more
core +1 more source
EUS-Guided Pancreatic Cyst Ablation: a Clinical and Technical Review [PDF]
, 2019 Purpose of Review Pancreatic cystic lesions represent a growing public health dilemma, particularly as our population ages and cross-sectional imaging becomes more sensitive.
DeWitt, John M. +2 more
core +1 more source
Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens [PDF]
, 2018 A pancreatoduodenectomy specimen is complex, and there is much debate on how it is best approached by the pathologist. In this review, we provide an overview of topics relevant for current clinical practice in terms of gross dissection, and macro- and ...
Brosens, L. (Lodewijk) +9 more
core +5 more sources
Intrahepatic Intraductal Papillary Cystic Neoplasm of the Bile Duct: A Case Report [PDF]
HPB, 2021 Intraductal papillary neoplasm of the bile duct (IPNB) is a tumour with a very low incidence in the Western world, characterised by a high risk of malignant transformation and unknown prognosis. It is a new entity which was adopted by the WHO in 2010 as a precursor lesion of cholangiocarcinoma.
Baltagiannis, Evangelos G. +5 more
openaire +2 more sources